News on everything: from our latest technology developments to new partnerships and publications.
Point-of-care and screening tests for early detection of Type 1 Diabetes
EpitogenX is delighted to announce the launch of an Innovate UK Knowledge Transfer Partnership (KTP) between our subsidiary, Vertebrate Antibodies, an
08 September, 2023
EpitoPredikt® and EpitoGen® combine to develop a diagnostic test for Lyme Disease (LD)
The diagnostic pathway in the UK follows a two-step approach using commonly available antibody screening tests. This process is lengthy, complex, expe
02 March, 2023
EpitoPredikt – Ongoing projects
AN AI model to predict IgA epitopes Mucosal immunization has numerous advantages over needle-based administrations; improved safety, self-delivery, ca
12 January, 2023